Instructions for use Alfazone

in Austria approved a new tool to increase potency - Alfazone capsules. The drug is available in the form of capsules with a soluble shell. The exclusive formula is based on natural ingredients from medicinal plants, which guarantees the safety of the product. Active substances have a cumulative property, therefore, in order to obtain the desired effect, the capsules must be taken according to the instructions.

How to use Alfazone

Alfazone are soluble capsules

For the treatment of erectile dysfunction, it is recommended to take one capsule in the morning and in the evening before or during meals, drinking plenty of clean, still water. The course of treatment can be 30 days, depending on the form and severity of erectile dysfunction. In order to avoid the drug can last 10-15 days, one capsule a day. To stimulate an erection before sexual intimacy, you need to drink two capsules 15 to 20 minutes before the intended act.

Indications for use of Alfazone capsules:

The reasons for developing erectile dysfunction and decreased libido can be different, but there are several signs by which you can determine the presence of a problem. Indications for taking Alfazone are:

  • weak attraction or its absence;
  • disappearance of morning or night erections;
  • very long interval between the beginning of the sexual act and the appearance of an erection;
  • difficulty reaching orgasm, pleasure itself is slightly expressed;
  • premature ejaculation;
  • decrease in the amount of semen excreted;
  • the impossibility of a repeated act after a brief rest;
  • the erection comes quickly, but disappears before the act;
  • complete impotence.

Contraindications for Alfazone capsules

Not recommended for anyone under 18 (only after puberty). Although clinical trials have not revealed allergic reactions, people with an individual intolerance to one of the components of the composition (damian, ginseng or zinc) should refrain from using the capsules. In addition, they cannot be used in the presence of oncological diseases of the genitourinary system.